Literature DB >> 10953333

p53 analysis of laryngeal cancer in exon 4 to 9.

S Gottschlich1, S Maune, J Preugschat, M Hoffmann, J A Werner, J D Maass, T Görögh, K Heidorn, H Rudert.   

Abstract

p53 gene mutations are a common genetic alteration in human cancer and codon 72/exon 4 polymorphism of the p53 gene has been implicated in cancer risk. Therefore in this study the p53 gene status of 32 shock-frozen tumor specimens from larynx carcinomas was analyzed by PCR and sequencing of exon 4 through 9. Four mutations (12.5%) in exon 5, 7, 8 and 9 were detected in the carcinoma specimen. Analysis of codon 72 revealed in eight cases a homozygosity for proline (CCC) and in 24 cases heterozygosity or homozygosity for arginine (CGC). The group with the proline/proline genotype had a median age 10.3 years lower than the remaining patients and included the only two non-smokers. Firstly, these results confirm the p53 mutational status of laryngeal cancer without any clinical correlation and secondly may suggest an oncogenic potential for the proline/proline genotype of codon 72 for laryngeal cancer as has already been assumed for lung cancer.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10953333

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  3 in total

1.  p53 codon 72 polymorphism and hepatocellular carcinoma: a meta-analysis.

Authors:  Shuting Jia; Wenru Tang; Ying Luo
Journal:  Hepatol Int       Date:  2012-08-03       Impact factor: 6.047

Review 2.  "P53 codon 72 single base substitution in viral hepatitis C and hepatocarcinoma incidences".

Authors:  Emad F Eskander; Ahmed A Abd-Rabou; Shaymaa M M Yahya; Ashraf El Sherbini; Mervat S Mohamed; Olfat G Shaker
Journal:  Indian J Clin Biochem       Date:  2013-04-04

3.  Analysis of R213R and 13494 g-->a polymorphisms of the p53 gene in individuals with esophagitis, intestinal metaplasia of the cardia and Barrett's Esophagus compared with a control group.

Authors:  Diogo André Pilger; Patrícia Luciana da Costa Lopez; Fábio Segal; Sandra Leistner-Segal
Journal:  Genomic Med       Date:  2007-05-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.